Aug. 21, 2018 Price forecast | 2 weeks: 1.03% | 1 month: 2.22% | 3 months: 6.99%


ATRS stock forecast

Our latest prediction for Antares Pharma, Inc.'s stock price was made on the Aug. 21, 2018 when the stock price was at 3.65$.

In the short term (2weeks), ATRS's stock price should outperform the market by 1.03%. During that period the price should oscillate between -7.25% and +10.34%.

In the medium term (3months), ATRS's stock price should outperform the market by 6.99%. During that period the price should oscillate between -14.93% and +27.43%.

Create a solid portfolio with ATRS

Add ATRS to your portfolio and optimize it!


About Antares Pharma, Inc.

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.

At the moment the company generates 59M USD in revenues.

On its last earning announcement, the company reported a loss of -0.11$ per share.

The book value per share is 0.16$

Antares Pharma, Inc. website


Three months stock forecastAug. 21, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
59M 51.40% -15M -25.40% -16M -0.11 - - 157M 0.16 -18M -1M -19M